3.2. Tolerance Assessment
ADVERSE EVENTS, ADVERSE EFFECTS, EVENTS
No adverse effects attributable to the intervention were reported during the study (no self-reported serious or nonserious adverse events = 0). There were no significant self-reported observations in the compliance calendars and in the Medical Symptoms Questionnaires (MSQ) completed at baseline and at the end of the study, suggesting that all participants followed the study plan provided to them at baseline, and experienced no undesirable events for 12 consecutive weeks of the study. No differences between groups were observed between the groups for the MSQ responses at baseline (